Navigation Links
Cardiome Reports First Quarter Results
Date:5/13/2008

bel safety study evaluating recent-onset AF patients, called ACT 4, has completed.

Vernakalant (oral) is being investigated as a chronic-use oral drug for the maintenance of normal heart rhythm following termination of AF. Cardiome announced positive results from a Phase 2a pilot study for vernakalant (oral) in September 2006. A Phase 2b study for vernakalant (oral) is ongoing.

In April 2007 Cardiome acquired exclusive worldwide rights for GED-aPC for all indications. Cardiome intends to initially develop GED-aPC in cardiogenic shock, a life-threatening form of acute circulatory failure due to cardiac dysfunction, which is a leading cause of death for patients hospitalized following a heart attack.

Cardiome is traded on the Toronto Stock Exchange (COM) and the NASDAQ National Market (CRME).

Forward-Looking Statement Disclaimer

Certain statements in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 or forward-looking information under applicable Canadian securities legislation that may not be based on historical fact, including without limitation statements containing the words "believe", "may", "plan", "will", "estimate", "continue", "anticipate", "intend", "expect" and similar expressions. Such forward-looking statements or information involve known and unknown risks, uncertainties and other factors that may cause our actual results, events or developments, or industry results, to be materially different from any future results, events or developments expressed or implied by such forward-looking statements or information. Such factors include, among others, our stage of development, lack of product revenues, additional capital requirements, risk associated with the completion of clinical trials and obtaining regulatory approval to market our products, the ability to protect our intellectual property, dependence on collaborative partners and the prospect
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Cardiome to Present at Bear Stearns Conference
2. Cardiome to Present at ThinkEquity Conference
3. Cardiome to Present at CIBC Conference
4. Cardiome To Release Third Quarter Results
5. Cardiome Initiates Phase 1 Study for GED-aPC
6. Cardiome Updates Guidance
7. Cardiome to Hold Investor Update Call
8. Cardiome And Astellas Announce Regulatory Update
9. Cardiome Announces Positive Interim Phase 2b Results for Oral Vernakalant and Engages Merrill Lynch as Strategic Advisor
10. Cardiome To Release 2007 Results
11. Cardiome To Release 2008 First Quarter Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Teens who are sensitive to light or noise after ... such as anxiety and depression, a new study says. ... issues teens experience after concussion may help in planning ... when to return to play and what accommodations are ... Koehl and Dong Han, of the University of Kentucky ...
(Date:7/10/2014)... Dennis Thompson HealthDay ... About six out of 10 adults make use of calorie ... order in restaurants, according to a new U.S. study. ... lead author, Seung Hee Lee-Kwan, an epidemiologist with the U.S. ... women surveyed said they used menu labeling to help choose ...
(Date:7/10/2014)... with a microchip-based device developed at the Massachusetts General ... MGH Cancer Center can be cultured to establish cell ... the July 11 issue of Science , an ... reflect a tumor,s genetic mutation over time and changing ... culture cells from the blood that represent those present ...
(Date:7/10/2014)... The U.S. Department of Health and Human Services ... (UH) Case Medical Center Seidman Cancer Center totaling $4.7 ... improving care for patients with complex cancer. , ... unique model developed at UH to enhance care for ... demonstrated need for high health care utilization. ...
(Date:7/10/2014)... Huddersfield could help to improve the quality of some ... as butter, mayonnaise, yoghurt and fruit drinks and ... her work. , Katerina gained her MSc degree in ... she has embarked on research for a PhD. ... investigating the potential of carbohydrates extracted from the pods ...
Breaking Medicine News(10 mins):Health News:Some Teens May Face Emotional Problems After Concussion 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 2Health News:60 Percent of Diners Use Calorie Labeling When Posted: CDC 3Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 2Health News:Cultured CTCs reveal genetic profile, potential drug susceptibility of breast cancer cells 3Health News:UH Case Medical Center awarded $4.7 million grant from HHS 2Health News:UH Case Medical Center awarded $4.7 million grant from HHS 3Health News:World interest in research work on the benefits of the Okra plant 2
... flying off the handle the next time someone cuts ... Yale School of Medicine researchers that links changes brought ... arrhythmias and sudden cardiac arrests, which are blamed for ... Lampert, M.D., associate professor of medicine at Yale School ...
... Feb. 24 Though the American Medical Association and ... funding of CME and though some big pharma companies ... even eliminating funding for CME by third-party vendors), 75 ... associations and teaching hospitals is funded by the bio-pharma ...
... from a baseball or hockey puck at just the right time could ... prevention were investigated in the March/April issue of Sports Health: A Multidisciplinary ... ... non-penetrating hit to the chest from a baseball or hockey puck at ...
... with the least education have a higher incidence of lung ... history accounts for approximately half of this risk, according to ... Journal of the National Cancer Institute. , Previous ... a higher risk for developing lung cancer. Some studies have ...
... chest pain are sent to a cardiologist to go through ... show no evidence of coronary artery disease which is the ... common occurrence in men, and these women are sent home ... their physicians complaining of similar symptoms and are more likely ...
... -- Ancient groundwater being tapped by Jordan, one of the ... to contain twenty times the radiation considered safe for drinking ... researchers. , "The combined activities of 228 radium and ... in the groundwater we tested are up to 2000 percent ...
Cached Medicine News:Health News:Educating the Market: Creating Value Through Support of Continuing Medical Education 2Health News:Study Shows Simple Measures May Help Prevent Sudden Death Event in Young Athletes 2Health News:Smoking behavior partially explains socioeconomic inequities in lung cancer incidence 2Health News:Cardiologists initiate STILETTO study to investigate treatment options for women with chest pain 2Health News:Jordan's fossil water source has high radiation levels 2Health News:Jordan's fossil water source has high radiation levels 3
(Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...
(Date:1/15/2014)... Most osteoporosis patients want a choice in the medication ... by Mission Pharmacal Company. The survey, conducted by ... community, revealed that 74 percent of osteoporosis patients surveyed ... other than a pill or a tablet. ...
(Date:1/15/2014)... today announced it has established a relief fund ... that has gripped much of the nation. AARP and its ... support these emergency relief efforts AARP and AARP Foundation will ... to $500,000 in aid. The matching program will be administered ...
Breaking Medicine Technology:Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3
... DUSA Pharmaceuticals, Inc.® (Nasdaq: DUSA ), a ... it has been named to Deloitte,s 2010 Technology Fast ... DUSA as one of the Top 500 fastest growing ... in North America.  Rankings are based on percentage of ...
... Oct. 26 Neurocrine Biosciences, Inc. (Nasdaq: NBIX ... Officer of Neurocrine Biosciences, will be presenting at the Oppenheimer ... The live presentation takes place on Tuesday, November 2, ... Time.  The presentation will be webcast and may be accessed ...
Cached Medicine Technology:DUSA Pharmaceuticals Named to Deloitte's 2010 Technology Fast 500 List of Fastest Growing Companies in North America 2
... SPECIFICATIONS Form: Granular, free-flowing powder EEO (-m r ): ... less than or equal to 35C Remelt Point (3%): ... greater than or equal to 300 gm/cm 2 ... than or equal to 0.10% DNase: Passes test RNase: ...
... sulfate (SO 4 ) ≤ 1000 mg/kg Cation traces: ... ≤ 5 mg/kg Cr ≤ 5 mg/kg Cu ≤ ... mg/kg Mg ≤ 50 mg/kg Mn ≤ 5 mg/kg ... ≤ 5 mg/kg Zn ≤ 5 mg/kg Special grade: ...
... ≤ 500 mg/kg sulfate (SO 4 ) ≤ 1000 ... 5 mg/kg Co ≤ 5 mg/kg Cr ≤ 10 ... K ≤ 5 mg/kg Mg ≤ 5 mg/kg Mn ... 5 mg/kg Pb ≤ 5 mg/kg Zn ≤ 5 ...
Inquire...
Medicine Products: